Full Text View
Tabular View
No Study Results Posted
Related Studies
Trial of an Anti-HIV-1 Gene Transfer Product
This study has been completed.
Study NCT00074997   Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
First Received: December 28, 2003   Last Updated: January 23, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
HIV Infections
Additional conditions recognized in this trial
Acquired Immunodeficiency Syndrome
Communicable Diseases
Infection
More general conditions related to this trial
Immune System Diseases
Immunologic Deficiency Syndromes
Lentivirus Infections
Retroviridae Infections
RNA Virus Infections
Sexually Transmitted Diseases
Sexually Transmitted Diseases, Viral
Slow Virus Diseases
Virus Diseases
Interventions listed in this trial
OZ1 (anti-HIV-1 gene)
Sponsors listed in this trial
Johnson &Johnson Pharmaceutical Research &Development, L.L.C.
Tibotec Pharmaceutical Limited


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services